Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Endometrial safety of ospemifene: results of the phase 2/3 clinical development program.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Endometrial safety of ospemifene: results of the phase 2/3 clinical development program.
Endometrial safety of ospemifene: results of the phase 2/3 clinical development program. Menopause. 2015 Jan; 22(1):36-43.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Atrophy
Double-Blind Method
Dyspareunia
Endometrial Hyperplasia
Endometrial Neoplasms
Endometrium
Female
Humans
Middle Aged
Placebos
Postmenopause
Selective Estrogen Receptor Modulators
Tamoxifen
Vagina
Vaginal Diseases
Vulva
authors with profiles
Steve A.n. Goldstein